NDC 15631-0546

CALADIUM SEGUINUM

Caladium Seguinum

CALADIUM SEGUINUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Dieffenbachia Seguine.

Product ID15631-0546_ecfb0f29-393e-4eb3-91a4-074300b248f2
NDC15631-0546
Product TypeHuman Otc Drug
Proprietary NameCALADIUM SEGUINUM
Generic NameCaladium Seguinum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameDIEFFENBACHIA SEGUINE
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0546-3

100 TABLET in 1 CONTAINER (15631-0546-3)
Marketing Start Date2015-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0546-7 [15631054607]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-1 [15631054601]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-6 [15631054606]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-0 [15631054600]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-4 [15631054604]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-2 [15631054602]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-3 [15631054603]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0546-5 [15631054605]

CALADIUM SEGUINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DIEFFENBACHIA SEGUINE3 [hp_X]/1

OpenFDA Data

SPL SET ID:4aa49d30-cd28-4b87-8db7-d18f325c53b1
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "CALADIUM SEGUINUM" or generic name "Caladium Seguinum"

    NDCBrand NameGeneric Name
    0220-1027Caladium seguinumDIEFFENBACHIA SEGUINE
    0220-1031Caladium seguinumDIEFFENBACHIA SEGUINE
    0220-1032Caladium seguinumDIEFFENBACHIA SEGUINE
    0220-1034Caladium seguinumDIEFFENBACHIA SEGUINE
    0220-1035Caladium seguinumDIEFFENBACHIA SEGUINE
    0220-1036Caladium seguinumDIEFFENBACHIA SEGUINE
    15631-0090CALADIUM SEGUINUMCALADIUM SEGUINUM
    15631-0546CALADIUM SEGUINUMCALADIUM SEGUINUM
    63545-622Caladium SeguinumCaladium Seguinum
    63545-623Caladium SeguinumCaladium Seguinum
    63545-624Caladium SeguinumCaladium Seguinum
    63545-625Caladium SeguinumCaladium Seguinum
    63545-626Caladium SeguinumCaladium Seguinum
    63545-627Caladium SeguinumCaladium Seguinum
    63545-628Caladium SeguinumCaladium Seguinum
    63545-629Caladium SeguinumCaladium Seguinum
    68428-271Caladium SeguinumDIEFFENBACHIA SEGUINE
    71919-141Caladium seguinumDIEFFENBACHIA SEGUINE
    69152-1166Caladium seguinum 200CCaladium seguinum

    © 2022 FDA.report
    This site is not affiliated with or endorsed by the FDA.